Durasphere
Commercial- Indications
- Stress urinary incontinence, Vesicoureteral reflux, Fecal incontinence, Gastroesophageal reflux disease
Company intelligence / Profile preview
Carbon Medical Technologies has developed and commercialized a range of implantable medical devices using proprietary pyrolytic carbon-coating technology. Their products are used for soft tissue augmentation (e.g., treatment of urinary incontinence), radiographic and fiducial marking for biopsies and radiation therapy planning, as well as applications in vascular and neurological procedures. The company operates an ISO13485 certified and FDA-GMP approved manufacturing facility[6][7]. Clinical results are not typically published for device companies at the same level as drug developers; however, their products are marketed globally through direct sales or distribution agreements.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carbon Medical Technologies.